InsidersTradesSigma
Discover the full record of transactions filed by Branning Todd P., Chief Financial Officer. Officer active across 1 companies, notably NeuBase Therapeutics, Inc.. Cumulatively, 2 disclosures have been published. Total volume traded: €31k. The latest transaction was disclosed on 18 March 2022 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
2 of 2 declarations
Todd P. Branning is the Chief Financial Officer of NeuBase Therapeutics, Inc. He is responsible for the company's financial management, including financial planning, risk management, and investment strategy. His role is essential in ensuring the financial health and growth of NeuBase.